The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of socioeconomic status on survival after CD19 CART therapy.
 
Haley Newman
No Relationships to Disclose
 
Yimei Li
No Relationships to Disclose
 
Hongyan Liu
No Relationships to Disclose
 
Vicky Tam
No Relationships to Disclose
 
Regina M Myers
No Relationships to Disclose
 
Amanda M DiNofia
No Relationships to Disclose
 
Colleen Callahan
Consulting or Advisory Role - Novartis
Speakers' Bureau - Peerview
 
Claire M White
Consulting or Advisory Role - Novartis
 
Diane Baniewicz
No Relationships to Disclose
 
Stephan Kadauke
Employment - Gilead Sciences (I); Immunomedics (I)
Research Funding - Miltenyi Biotec
Travel, Accommodations, Expenses - Astellas Pharma; Novartis
 
Caroline Diorio
No Relationships to Disclose
 
David T. Teachey
Consulting or Advisory Role - Sobi
Research Funding - Beam Therapeutics (Inst); NeoImmuneTech (Inst); Novartis (Inst)
 
Susan R. Rheingold
Employment - OptiNose (I)
Stock and Other Ownership Interests - OptiNose (I)
Consulting or Advisory Role - Pfizer
Research Funding - Pfizer (Inst)
 
Kelly D. Getz
No Relationships to Disclose
 
Carl H. June
Leadership - AC Immune
Stock and Other Ownership Interests - Bluesphere Bio; Cabaletta Bio; Carisma Therapeutics; Cellares; Celldex; DeCART Therapeutics; Decheng Capital; Posieda Therapeutics; Tmunity Therapeutics, Inc.; Verisma; ZIOPHARM Oncology
Honoraria - Pfizer
Consulting or Advisory Role - Cabaletta Bio; Carisma Therapeutics; Celldex; Janssen Oncology; Kiadis Pharma; Viracta Therapeutics; WIRB-Copernicus Group; WIRB-Copernicus Group
Research Funding - Novartis; Tmunity Therapeutics, Inc.
Patents, Royalties, Other Intellectual Property - IP licensed to Novartis; Royalties paid to University of Pennsylvania; IP licensed to Tmunity (Inst); Office of Naval Research; IP and patent royalties
 
Richard Aplenc
Expert Testimony - Vorys, Sater, Seymour, and Pease LLP
 
Shannon L. Maude
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); WUGEN, Inc. (Inst)
Travel, Accommodations, Expenses - Novartis
 
Stephan A. Grupp
Consulting or Advisory Role - Adaptimmune; Alimera Sciences; Cabaletta Bio; Cellular Biomedicine Group; crispr therapeutics/Vertex; Humanigen; Janssen; Jazz Pharmaceuticals; Novartis; Roche; TCR2 Therapeutics
Research Funding - Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); Novartis (Inst); SERVIER (Inst); Vertex (Inst)
Patents, Royalties, Other Intellectual Property - UPenn Toxicity management patent (Inst)
Expert Testimony - Juno Therapeutics
 
Kira Bona
No Relationships to Disclose
 
Allison Emily Barz Leahy
No Relationships to Disclose